TY - JOUR
KW - antidiabetic drug
KW - hypoglycaemia
KW - pharmaco‐epidemiology
KW - real‐world evidence
KW - sulphonylureas
AU - J. Dimakos
AU - Y. Cui
AU - R. Platt
AU - C. Renoux
AU - K. Filion
AU - A. Douros
AD - Department of Medicine, McGill University, Montreal, Canada.
Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, Canada.
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Department of Pediatrics, McGill University, Montreal, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
AN - 38698651
BT - Diabetes Obes Metab
DO - 10.1111/dom.15627
DP - NLM
ET - 2024/05/03
LA - eng
N1 - 1463-1326
Dimakos, Jenny
Cui, Ying
Platt, Robert W
Renoux, Christel
Filion, Kristian B
Orcid: 0000-0001-6055-0088
Douros, Antonios
Orcid: 0000-0002-6005-4006
PJT-165882/CAPMC/CIHR/Canada
Journal Article
England
Diabetes Obes Metab. 2024 May 2. doi: 10.1111/dom.15627.
PY - 2024
SN - 1462-8902
T2 - Diabetes Obes Metab
TI - Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study
ER -